Compare Hims and Hers Health Inc (HIMS) vs Microsoft (MSFT) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

Microsoft (MSFT) trades at $399.48, up 1.44% today, with strong technical momentum as the stock approaches resistance at $407. The company demonstrates robust fundamentals with Q1 2026 EPS beating expectations at $4.27 versus $4.06, continuing a trend of earnings outperformance. Revenue growth remains solid with 2025 revenue reaching $281.72 billion and net income of $101.83 billion, supported by strong cash flow generation of $136.16 billion from operations.

Microsoft's outlook remains positive with 80% analyst buy ratings and a $546.70 consensus price target representing 37% upside potential. Key opportunities include AI leadership through Azure and Copilot, while risks include elevated capital expenditures and competitive pressures in cloud computing. The stock's current valuation at 23.96 P/E appears reasonable given growth prospects.